Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-01-15 @ 3:34 PM
Study NCT ID:
NCT00796120
Status:
COMPLETED
Last Update Posted:
2015-12-10
First Post:
2008-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization: